Your browser doesn't support javascript.
loading
Phase I/II trial of dose-reduced capecitabine in elderly patients with advanced colorectal cancer.
Vincent, M D; Breadner, D; Cripps, M C; Jonker, D J; Klimo, P; Biagi, J J; Lam, W; O'Connell, A; Whiston, F; Stitt, L; Welch, S A.
Afiliação
  • Vincent MD; London Regional Cancer Program, London, ON.
  • Breadner D; Schulich School of Medicine and Dentistry, London, ON.
  • Cripps MC; London Regional Cancer Program, London, ON.
  • Jonker DJ; Schulich School of Medicine and Dentistry, London, ON.
  • Klimo P; Department of Medical Oncology, The Ottawa Hospital Cancer Centre, Ottawa, ON.
  • Biagi JJ; Department of Medical Oncology, The Ottawa Hospital Cancer Centre, Ottawa, ON.
  • Lam W; Medical Oncology, Lions Gate Hospital, North Vancouver, BC.
  • O'Connell A; Department of Oncology, Queen's University, Kingston, ON.
  • Whiston F; Burnaby Hospital Cancer Centre, Burnaby, BC.
  • Stitt L; London Regional Cancer Program, London, ON.
  • Welch SA; London Regional Cancer Program, London, ON.
Curr Oncol ; 24(4): e261-e268, 2017 Aug.
Article em En | MEDLINE | ID: mdl-28874896
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Ano de publicação: 2017 Tipo de documento: Article